<p>DCs were carefully washed to eliminate cytokines and dexamethasone, and viable DCs were further re-challenged with 100 ng/ml of LPS or 1 µg/ml of soluble CD40L as second stimuli. After 24 h, the phenotype (<b>A</b>) was analyzed by flow cytometry. Data represent relative MFI increase induced by LPS (n = 6) or CD40L (n = 4) compared to unstimulated iDCs, mDCs or tol-DCs as control. (<b>B</b>) IL-10 concentration is shown in pg/ml. IL-12p70 and IL-23 were not detected (detection limit = 7.8 pg/ml). Student’s <i>t</i>-test: *<i>p</i><0.05, **<i>p</i><0.001. (<b>C</b>) Tol-DCs do not recover the ability to stimulate T cells after re-challenge. T-cell proliferation was determined in triplicate by <sup>3</sup>H-thymidine incorporation. IFN-γ a...
<p><b>A</b>) Flow cytometry for DC markers in immature DCs (iDCs), DCs matured with a standard proto...
<p><b>A)</b> Top: Autologous proliferation of T cells (% proliferation using CFSE) after stimulation...
<p>After 12 h exposure to ManLAM and/or PIM (at the concentration of 10 µg/ml and 5 µg/ml, respectiv...
<p>(<b>A</b>) Maturation associated molecules upregulation in DCs from Crohn’s disease patients are ...
<p>(A) Real-Time PCR was used to assess IL-12p35, IL-12p40 and IL-10 mRNA on single cell levels befo...
<p>(<b>A</b>) DCs were cultured with allogeneic PBL at different ratio (1∶20 or 1∶100) for seven day...
<p>DCs matured as described in the methods section were labeled with anti-CD11c and either anti-CD86...
<p>(<b>A</b>) Phenotypic analysis of untreated (iDCs), cytokine-activated (mDCs) and 10<sup>−6</sup>...
<p>Monocyte-derived DCs from healthy individuals were generated without (control) or with IFN-λ (com...
<p>MLR was induced by CD1a+ and CD1a−negative DC purified at day 3 of monocyte differentiation (imma...
<p>A) Autologous proliferation of T cells (c.p.m. for <sup>3</sup>H thymidine assay) after stimulati...
<p>(A) DC membrane molecule expression at 6 (dotted line) and 24 hours (black line) after LPS or LPS...
<p>(A) Human DCs were pre-incubated with 20<i> </i>µg/mL of anti-TLR2, anti-TLR4, or IgG2a (as an is...
<p>(A) Flow cytometry analysis of intracellular IL-12<sub>p40</sub> in MGL2<sup>+</sup> dDCs, MGL2<s...
<p>DCs generated from peripheral blood of healthy donors were analyzed for their cytokine secretion ...
<p><b>A</b>) Flow cytometry for DC markers in immature DCs (iDCs), DCs matured with a standard proto...
<p><b>A)</b> Top: Autologous proliferation of T cells (% proliferation using CFSE) after stimulation...
<p>After 12 h exposure to ManLAM and/or PIM (at the concentration of 10 µg/ml and 5 µg/ml, respectiv...
<p>(<b>A</b>) Maturation associated molecules upregulation in DCs from Crohn’s disease patients are ...
<p>(A) Real-Time PCR was used to assess IL-12p35, IL-12p40 and IL-10 mRNA on single cell levels befo...
<p>(<b>A</b>) DCs were cultured with allogeneic PBL at different ratio (1∶20 or 1∶100) for seven day...
<p>DCs matured as described in the methods section were labeled with anti-CD11c and either anti-CD86...
<p>(<b>A</b>) Phenotypic analysis of untreated (iDCs), cytokine-activated (mDCs) and 10<sup>−6</sup>...
<p>Monocyte-derived DCs from healthy individuals were generated without (control) or with IFN-λ (com...
<p>MLR was induced by CD1a+ and CD1a−negative DC purified at day 3 of monocyte differentiation (imma...
<p>A) Autologous proliferation of T cells (c.p.m. for <sup>3</sup>H thymidine assay) after stimulati...
<p>(A) DC membrane molecule expression at 6 (dotted line) and 24 hours (black line) after LPS or LPS...
<p>(A) Human DCs were pre-incubated with 20<i> </i>µg/mL of anti-TLR2, anti-TLR4, or IgG2a (as an is...
<p>(A) Flow cytometry analysis of intracellular IL-12<sub>p40</sub> in MGL2<sup>+</sup> dDCs, MGL2<s...
<p>DCs generated from peripheral blood of healthy donors were analyzed for their cytokine secretion ...
<p><b>A</b>) Flow cytometry for DC markers in immature DCs (iDCs), DCs matured with a standard proto...
<p><b>A)</b> Top: Autologous proliferation of T cells (% proliferation using CFSE) after stimulation...
<p>After 12 h exposure to ManLAM and/or PIM (at the concentration of 10 µg/ml and 5 µg/ml, respectiv...